EVP Richard R. DeLuca sold 37,685 MRK shares at $120.92, reducing holdings by 19.0% to 160,173 shares; stock near 52-week high.
Richard R. DeLuca, EVP and President of Merck Animal Health, sold 37,685 shares for $4,557,024.71, representing a 19.0% reduction in his holdings. The sale occurred at $120.92, just 0.0% below the current 52-week high of $121.93, and follows a sharp 12.3% gain over 30 days and 41.3% gain over 90 days. Examined across his prior three MRK sales (all in 2023), two resulted in negative 90-day subsequent returns, meaning he sold ahead of declines—a 66.67% well-timed rate on his cross-ticker history. The current sale at the 52-week high against the backdrop of his prior pattern of sales before pullbacks warrants attention, though Merck's fundamentals remain solid with $17.3B quarterly revenue, $5.8B net income, and a P/E of 15.90.